Curriculum Vitaes

Usuki Toyonobu

  (臼杵 豊展)

Profile Information

Affiliation
Associate Professor, Faculty of Science and Technology, Department of Materials and Life Sciences, Sophia University
Degree
Bachelor of Science(Tohoku University)
修士(理学)(東北大学)
Doctor of Science(Tohoku University)

Contact information
t-usukisophia.ac.jp
Researcher number
50514535
J-GLOBAL ID
200901076489387829
researchmap Member ID
5000046104

Papers

 113
  • Christian Nanga Chick, Francois Eya'ane Meva, Phillippe Belle Ebanda Kedi, Toyonobu Usuki
    Nano Select, Jul 17, 2024  
    ABSTRACT This study examined the synthesis of silver nanoparticles (SNPs) with aqueous extracts of Cyclosorus dentatus and Nephrolepis biserrata fronds and the evaluation of their biological activities. Mixing of AgNO3 solution and the aqueous extracts resulted in color change, indicating the formation of SNPs. UV‐Vis spectroscopy analysis gave a surface plasmon resonance (SPR) peak at approximately 420 nm, confirming the presence of the synthesized SNPs. Infrared analysis showed C‐O, N‐O, and C‐C vibrations or stretching and aliphatic vibrations of hydrocarbon chains of the synthesized SNPs. x‐Ray diffraction (XRD) analysis indicated the SNPs were face‐centered, cubic, and crystalline in nature, with crystallite sizes. The scanning electron microscopy (SEM) shows the aggregation of the spherical shape nanoparticles. The SNPs significantly reduced phosphomolybdenum and captured H2O2 with respective IC50 values of 61.55 and 29.03 µg/mL for C. dentatus SNP (SNP‐Cd), and 92.61 and 9.07 µg/mL for N. biserrata SNP (SNP‐Nb), respectively. In terms of albumin‐denaturing activity, the SNPs gave an IC50 value of 21.20 µg/mL for SNP‐Cd and 7.18 µg/mL for SNP‐Nb. Thus, this work confirmed that SNP‐Cd and SNP‐Nb are potential therapeutic agents for treating oxidative stress, inflammatory problems, and related diseases.
  • Eri Tanaka, Yukie Yokota, Masamitsu Urakawa, Toyonobu Usuki
    European Food Research and Technology, Apr 21, 2024  
  • Lokadi Pierre Luhata, Yusuke Yoshida, Toyonobu Usuki
    Bioorganic Chemistry, 147 107389-107389, Apr, 2024  Peer-reviewedCorresponding author
    The leaves of Odontonema strictum, a tropical plant used for its antihypertensive properties, are rich in nutrients and biologically active phytochemicals, such as β-sitosterol, stigmasterol, umuravumbolide, deacetylumuravumbolide, dideacetylboronolide, deacetylboronolide, verbascoside, and isoverbascoside. In addition, its roots are rich in β-sitosterol, stigmasterol, and the iridoid glycoside β-O-methyl-unedoside. Ingestion of the roots was reported to have a sedative effect in a dog was previously reported on a dog eating the roots of this plant. In the present study, we report for the first time the cell proliferation- and neurite outgrowth-promoting effects in PC12 neuronal cells of the isolated organic compounds and crude extracts from O. strictum. Pituitary adenylate cyclase-activating peptide (PACAP) and quercetin were used as positive controls. At the concentration of 0.2 μg/mL, β-sitosterol was more potent than quercetin and displayed the same activity (>45 μm/cell) as PACAP (100 nM). At a low concentration (0.04 μg/mL), verbascoside and isoverbascoside showed the strongest neurite outgrowth-promoting effect (neurite length of 30 to 35 μm/cell). Our results indicate that phytomedicines made from O. strictum may be useful in preventing neurodegenerative diseases.
  • Ryosuke Shigeta, Takahiro Suzuki, Kazuki Kaneko, Hiroaki Tanaka, Ibuki Haishima, Kanata Norio, Ayano Tanaka-Yanuma, Toyonobu Usuki
    Organic & Biomolecular Chemistry, 22(23) 4637-4640, Apr, 2024  Peer-reviewedCorresponding author
    Jamaicamide B was isolated from the cyanobacterium Moorea producens in Jamaica and shows neurotoxicity. Herein we report the first total synthesis and structural confirmation of the marine natural product (9R)-jamaicamide B.
  • Hiroaki Tanaka, Seiya Miyagi, Tomoko Morita, Hiroaki Ishii, Natsuki Mori, Kaho Oishi, Takemasa Sakaguchi, Toyonobu Usuki
    Helvetica Chimica Acta, 107(2), Feb 8, 2024  Corresponding author
    Abstract Umifenovir is a broad‐spectrum antiviral agent used to treat influenza in China and Russia, and it has been studied as an antiviral agent for the treatment of coronavirus disease 2019 (COVID‐19). We have previously reported the synthesis of novel umifenovir analogues and their biological evaluation with a focus on their inhibitory activity against the binding of the spike glycoprotein (S‐protein) of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) and the angiotensin‐converting enzyme 2 (ACE2) receptor; however, no strong inhibitory activity was observed from these analogues. In the present study, an additional set of umifenovir analogues was synthesized with replacement of the substituents at the 2‐, 3‐, and 4‐positions of the indole, and a cell‐based assay using SARS‐CoV‐2 (B.1.1) was performed to examine the antiviral activity of the analogues. We found that one of the newly synthesized umifenovir analogues exhibited antiviral activity and reduced the viral load to 0.06 % as compared to the control when it was assessed in the presence of nafamostat and marimastat, which inhibit cell‐surface viral entry. In contrast, when this analogue was evaluated without the addition of nafamostat or marimastat, it exhibited less antiviral activity, suggesting that the umifenovir analogue would exert antiviral activity mainly by inhibiting endosome‐mediated viral entry.

Misc.

 2

Books and Other Publications

 2

Presentations

 281

Research Projects

 22

Other

 7